Drug Discovery Services and Facilities
With facilities around the world and an unparalleled scope of capabilities in targets, platforms, and therapeutic areas, we can support your discovery programs from hit ID to IND.
-
Budapest and Szeged, Hungary
These two sites in Budapest and Szeged, Hungary, provide world-leading in vitro ADME services with a focus on drug transporters and drug-drug interactions.
-
Cambridge, UK
Our facility in Chesterford Research Park provides drug discovery services to a wide range of partners across multiple therapeutic areas. These collaborations cover the spectrum from small, single-discipline projects to fully integrated projects involving biology, medicinal chemistry, and ADME/PK.
Chesterford Research Park hosts highly qualified staff with experience working across all major druggable target classes and therapeutic areas. They are considered one of our centers of excellence for integrated drug discovery.
-
Freiburg, Germany
Our facility in Freiburg, Germany, is uniquely positioned to provide a comprehensive portfolio of non-GLP oncology services. A pioneer in patient-derived xenograft models, this facility now offers a wide range of in vitro and in vivo services catering to all type of cancer therapies.
-
High Peak, UK
Our High Peak, UK facility is a specialist biotechnology site with proprietary Cell Microarray Technology located in the heart of the UK’s Peak District national park. This site provides unique receptor ID/off-target screening services to accelerate, inform, and improve the safety of the discovery and pre-clinical development process for clients. We are recognized as leading technology within the biotherapeutic field.
-
Kuopio, Finland
Our facility in Kuopio, Finland, is a discovery center of excellence located in a global hub of neuroscience research. The site focuses on non-GLP in vitro and in vivo pharmacology studies. The capabilities at the site include comprehensive small animal imaging, behavioral, cognitive and physiological testing, histology services, and in vitro assays.
-
Leiden, The Netherlands
Our facility in Leiden, The Netherlands, uses a combination of functional genomics technologies coupled with human (primary) cells to identify and validate critical proteins in disease pathways. The team has in-depth expertise both in developing and performing disease-relevant assays and in setting up complex, high quality screens.
-
Portishead, UK
Our facility in Portishead, UK, offers world-leading expertise and capabilities in immunology, inflammation, and infectious disease drug discovery. Specialty areas include cell biology, in vivo pharmacology, bioanalytical services, clinical biomarkers, predictive immunotoxicology, and vaccine development.
-
Worcester, MA
Our facility in Worcester, MA, is focused on providing world-class in vitro ADME, in vivo PK/PD, bioanalytical and pharmacology testing services for the biotechnology and pharmaceutical industries. Our Worcester scientists help clients expedite their drug discovery and development by providing quality data earlier in the research process via technologies and systems that increase turnaround speed well beyond industry standards.
Discovering and characterizing novel drugs depends on innovative and reliable science. Our multidisciplinary drug discovery expertise and scope of capabilities allow us to deliver data and insight clients can trust to progress.
eBook: "Translational Strategies Accelerate Drug Discovery"
This eBook focuses on translational science and discovery partnerships that advance novel therapies through a collective momentum, leveraging efficiencies in drug discovery to accelerate nonclinical research and increase clinical success.
Download the eBook